logo
Coverys Report Reveals Diagnostic Errors Occur Most Frequently in Office-Based Care

Coverys Report Reveals Diagnostic Errors Occur Most Frequently in Office-Based Care

Business Wire2 days ago
BOSTON--(BUSINESS WIRE)-- Coverys, a leading provider of medical professional liability (MPL) insurance and healthcare risk management services, today released the second report in a three-part series, A Dose of Insight – Hidden in Plain Sight: Exposing the Drivers of Diagnostic Error, Part Two: Office-Based Practice.
Drawing on an in-depth analysis of Coverys medical malpractice claims from 2020 to 2024, the report highlights the ongoing and often underestimated threat of diagnostic errors in office-based practices. It brings attention to critical patterns—such as the frequent occurrence of missed cancer diagnoses—and underscores the need for greater awareness and system-level improvements to support more accurate and timely diagnoses. The report's key findings include:
Key Findings:
27% of malpractice events closed during the five-year period studied involved diagnostic error.
Diagnostic error occurs most frequently in office-based settings, accounting for 34% of diagnosis-related events.
45% of office-based events alleged a missed cancer diagnosis. The most common missed cancers were prostate, lung, breast, and colorectal.
One-third of office-based diagnostic error events resulted in a patient's death, and 22% resulted in a patient suffering a high-severity injury. Together, these tragic events accounted for 72% of the indemnity paid.
'Improving diagnostic accuracy is one of the most meaningful ways we can enhance patient safety,' said Dana Siegal, RN, CPHRM, CPPS, Vice President, Risk Management and Analytics at Coverys. "Unlike office-based procedures which are generally less urgent and complex than those performed in surgical or labor and delivery settings, diagnostic errors—particularly in outpatient settings—pose an underestimated threat to the safety and quality of patient care. This report provides data-informed actionable guidance to help clinicians recognize and address these risks, ultimately aiming to minimize patient harm."
Understanding and addressing the key vulnerabilities and commonly missed diagnoses identified in this report can significantly reduce diagnostic errors in the office setting. While the data highlights serious challenges, the empirical analysis also offers insights into five practical actions providers can take to enhance diagnostic accuracy and eliminate the hidden drivers of diagnostic errors in office-based care.
The report is the second installment in a three-part series examining diagnostic challenges in three care settings. The series began with an in-depth analysis of emergency departments, where diagnostic accuracy is often compromised by high patient volumes and time-sensitive decision-making. A future report will examine inpatient care and the unique diagnostic risks faced by hospitalized patients and their clinical teams.
In alignment with this important work, the Coverys Community Healthcare Foundation, Inc. (CCHF) is pleased to announce a new grant opportunity focused on reducing diagnostic error and enhancing patient outcomes. Grants will support innovative programs in the following settings: Emergency Department, Office-Based Practice, and Hospital Inpatient Care. For more information and to apply, visit the CCHF Grant Page.
The Dose of Insight report was co-authored by Dana Siegal, RN, CPHRM, CPPS, Vice President, Risk Management & Analytics; Maryann Small, MBA, Senior Director, Business Analytics; Susan L. Montminy, EdD, MPA, BSN, RN, FASHRM, CPHRM, CPPS, Senior Director, Risk Management & Analytics; Marlene Icenhower, BSN, JD, CPHRM, Senior Risk Specialist, Risk Management & Analytics; Patricia Bennett, RN, CPC, Senior Manager Clinical Coding, Business Analytics; Michelle Bondurant, RN, CP, Clinical Data Manager, Business Analytics.
The full report is available at Coverys.com
About Coverys
With close to $4 billion in assets and 50 years of protecting healthcare, Coverys is a leading provider of medical professional liability insurance. Coverys offers a full range of healthcare liability insurance options, complemented by advanced data analytics, evidence-based processes, and best-in-class risk management and education resources. With Coverys, healthcare providers can confidently focus on improving clinical, operational, and financial outcomes. For more information, visit coverys.com.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Wellness Innercell Expands into Indonesian Home Shopping Market with Joint Care
Wellness Innercell Expands into Indonesian Home Shopping Market with Joint Care

Business Wire

time6 hours ago

  • Business Wire

Wellness Innercell Expands into Indonesian Home Shopping Market with Joint Care

CHANGWON, South Korea--(BUSINESS WIRE)-- Wellness Innercell, a cosmetics manufacturer and distributor of health functional food, announced that it will launch its flagship health supplement product, 'Joint Care,' on Indonesian home shopping channels starting this October. 'In addition to our ongoing exports to the U.S., we will focus on pioneering new markets in Southeast Asia, starting with Indonesia in the second half of this year.' Share According to the company, Joint Care addresses the side effects and cost burden often associated with conventional joint supplements. It helps relieve joint pain while supporting cartilage protection, nerve and muscle health, dental care, bone density improvement, enhanced physical performance, immune system function, and energy production. Certified by the Korean Ministry of Food and Drug Safety as a health functional food, it contains key active ingredients at the maximum daily allowable dosage and includes probiotics to promote digestive health. Leveraging a multi-formula technology, Joint Care combines a variety of functional ingredients into a single all-in-one tablet, offered in convenient PTP (Press-Through Package) form for easy carrying and consumption. 'In addition to our ongoing exports to the U.S., we will focus on pioneering new markets in Southeast Asia, starting with Indonesia in the second half of this year,' said Kang Ik-geun, CEO of Wellness Innercell. About Wellness Innercell Wellness Innercell is a Korea-based manufacturer and distributor specializing in cosmetics and health functional foods, dedicated to delivering innovative, science-backed solutions for better living. Leveraging advanced formulation technology and strict quality standards, Wellness Innercell aims to expand its global presence and provide trusted health products to consumers worldwide.

The Root Brands Achieves Major Milestone, ranked #1922 on Prestigious Inc. 5000 List of America's Fastest-Growing Private Companies
The Root Brands Achieves Major Milestone, ranked #1922 on Prestigious Inc. 5000 List of America's Fastest-Growing Private Companies

Business Upturn

time7 hours ago

  • Business Upturn

The Root Brands Achieves Major Milestone, ranked #1922 on Prestigious Inc. 5000 List of America's Fastest-Growing Private Companies

Franklin, TN, Aug. 13, 2025 (GLOBE NEWSWIRE) — The Root Brands, a breakthrough health and wellness company, achieved #1922 on the prestigious 2025 Inc. 5000 list of America's fastest-growing private companies. This elite recognition validates explosive revenue growth from $3 million to $61 million over four years, powered by patented nanotechnology detox solutions and innovative wellness products. 'This Inc. 5000 recognition validates our mission to revolutionize global health through natural detoxification and cutting-edge wellness solutions,' said Clayton Thomas, Founder and CEO. 'We're transforming lives worldwide by making premium health products accessible to everyone, everywhere.' Breakthrough Patented Technology Drives Market Disruption The Root Brands' meteoric rise stems from Dr. Christina Rahm's revolutionary patented formulations, including breakthrough water-soluble clinoptilolite technology for advanced detoxification. With 18 patent-pending innovations and 6 approved patents, Dr. Rahm's proprietary nanotechnology has created industry-leading wellness supplements that deliver measurable health results. The Trinity® Products – the company's flagship three-product system featuring Clean Slate®, Zero-In®, and Restore® – work synergistically to deliver comprehensive wellness results. This powerful trinity performs complete detoxification, mental clarity enhancement, and cellular restoration, creating the foundation for optimal health. This groundbreaking three-step approach has captured 220,000+ loyal customers across 90+ countries seeking effective holistic wellness solutions. 'Cure the Causes®' – Registered Healthcare Revolution Dr. Rahm's 'Cure the Causes®' philosophy, officially trademarked in July 2025, represents a paradigm shift from symptom treatment to root cause healing. This holistic healthcare approach has been translated into 27 languages, creating a global wellness movement that drives customer loyalty and organic growth. Power Partnership Fuels Success The dynamic partnership between CEO Clayton Thomas and his wife, Dr. Christina Rahm (Chief Science Officer), has pushed The Root Brands to unprecedented success. Their combined expertise in business strategy and scientific innovation creates a competitive advantage that competitors cannot replicate. Franklin Corporate Excellence The Root Brands' corporate headquarters in Franklin, Tennessee, drives continuous innovation across products, staff development, and global operations. This dedicated team ensures consistent delivery of premium wellness solutions to customers worldwide. Ambassador-Driven Marketing Success Unlike traditional advertising, The Root Brands achieves explosive growth through authentic customer testimonials and ambassador advocacy. Real success stories from satisfied customers create powerful word-of-mouth marketing that builds trust and drives organic expansion across global markets. The ROOT Prime subscription program ensures consistent product delivery while customer success stories fuel sustainable growth, creating a self-perpetuating business model that continues expanding internationally. About The Root Brands Founded in 2020 in Franklin, Tennessee, The Root Brands develops premium natural health supplements, detox products, and wellness solutions using patented nanotechnology. The company's 'Cure the Causes®' methodology focuses on root cause healing through advanced detoxification, serving customers in 90+ countries with organic, non-GMO, vegan, and gluten-free formulations. Core Products: The Trinity System (Clean Slate, Zero-In, Restore), Natural Barrier Support (immunity), Relive Greens (nutrition) Key Metrics: 220,000+ customers | 90+ countries | 20x growth since 2020 About Inc. 5000 The Inc. 5000 ranks America's fastest-growing private companies based on percentage revenue growth from 2021-2024, requiring minimum revenues of $100,000 (2021) and $2 million (2024). Past honorees include Microsoft, Facebook, Under Armor, and Chobani. Media Contact: Marty McGinley – VP MarketingThe Root BrandsPhone: (980) 400-3245 Email: [email protected] Address: 393 Nichol Mill Lane, Unit 250B, Franklin, TN 37067 Website:

Amber Specialty Pharmacy Begins Dispensing Newly Approved BRINSUPRI™ (brensocatib) for Non-Cystic Fibrosisbronchiectasis (NCFB)
Amber Specialty Pharmacy Begins Dispensing Newly Approved BRINSUPRI™ (brensocatib) for Non-Cystic Fibrosisbronchiectasis (NCFB)

Business Wire

time10 hours ago

  • Business Wire

Amber Specialty Pharmacy Begins Dispensing Newly Approved BRINSUPRI™ (brensocatib) for Non-Cystic Fibrosisbronchiectasis (NCFB)

OMAHA, Neb.--(BUSINESS WIRE)--Amber Specialty Pharmacy, a pioneer in specialty pharmacy for more than 25 years, today announced it is now dispensing BRINSUPRI™ (brensocatib) following the medication's U.S. Food and Drug Administration (FDA) approval as the first treatment specifically indicated to reduce pulmonary exacerbations in adults and adolescents with non-cystic fibrosis bronchiectasis, a chronic neutrophil-mediated airway disease. 'Our nationally recognized clinical program is ready to ensure rapid access, personalized counseling, and comprehensive reimbursement support for every patient who needs it,' said Kristin Williams, president of Amber Specialty Pharmacy. Amber Specialty Pharmacy streamlines the treatment process for both patients and referring providers by offering the following support services: Nationwide dispensing through its URAC and ACHC-accredited network 24/7 clinical support and adherence counseling from specialty-licensed pharmacists End-to-end benefits investigation, prior authorization and financial assistance coordination Healthcare providers can initiate BRINSUPRI referrals by calling (888) 370-1724 or visiting to download electronic referral forms. About Amber Specialty Pharmacy Amber Specialty Pharmacy is a pioneer in the specialty pharmacy industry, with more than 25 years of experience in providing specialized care for patients with chronic and complex medical conditions. With a focus on personalized support and quality clinical care, Amber Specialty Pharmacy serves patients across the United States. The pharmacy is accredited by both the Utilization Review Accreditation Commission (URAC) and the Accreditation Commission for Health Care (ACHC). Amber Specialty Pharmacy is headquartered in Omaha, Nebraska. To learn more, visit

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store